RecallDepth
Class II Ongoing

Vial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-6637-24. Case NDC: 00409-6637-14.

Company
Pfizer Inc.
Recall Initiated
August 4, 2025
Posted
August 27, 2025
Recall Number
D-0591-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
15,750 vials
Firm Location
New York, NY, United States

Reason for Recall

Lack of Assurance of Sterility.

Distribution

U.S. Nationwide

Lot / Code Info

Lot #: LH2671, Exp. 11/30/2026

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class II Drug recalls